1574 related articles for article (PubMed ID: 19713445)
1. Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma.
Fens N; Zwinderman AH; van der Schee MP; de Nijs SB; Dijkers E; Roldaan AC; Cheung D; Bel EH; Sterk PJ
Am J Respir Crit Care Med; 2009 Dec; 180(11):1076-82. PubMed ID: 19713445
[TBL] [Abstract][Full Text] [Related]
2. An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD.
Dragonieri S; Annema JT; Schot R; van der Schee MP; Spanevello A; Carratú P; Resta O; Rabe KF; Sterk PJ
Lung Cancer; 2009 May; 64(2):166-70. PubMed ID: 18834643
[TBL] [Abstract][Full Text] [Related]
3. External validation of exhaled breath profiling using an electronic nose in the discrimination of asthma with fixed airways obstruction and chronic obstructive pulmonary disease.
Fens N; Roldaan AC; van der Schee MP; Boksem RJ; Zwinderman AH; Bel EH; Sterk PJ
Clin Exp Allergy; 2011 Oct; 41(10):1371-8. PubMed ID: 21732998
[TBL] [Abstract][Full Text] [Related]
4. An electronic nose in the discrimination of patients with asthma and controls.
Dragonieri S; Schot R; Mertens BJ; Le Cessie S; Gauw SA; Spanevello A; Resta O; Willard NP; Vink TJ; Rabe KF; Bel EH; Sterk PJ
J Allergy Clin Immunol; 2007 Oct; 120(4):856-62. PubMed ID: 17658592
[TBL] [Abstract][Full Text] [Related]
5. Breath profiles by electronic nose correlate with systemic markers but not ozone response.
Biller H; Holz O; Windt H; Koch W; Müller M; Jörres RA; Krug N; Hohlfeld JM
Respir Med; 2011 Sep; 105(9):1352-63. PubMed ID: 21439804
[TBL] [Abstract][Full Text] [Related]
6. Comparison of inspiratory and expiratory resistance and reactance in patients with asthma and chronic obstructive pulmonary disease.
Paredi P; Goldman M; Alamen A; Ausin P; Usmani OS; Pride NB; Barnes PJ
Thorax; 2010 Mar; 65(3):263-7. PubMed ID: 20335298
[TBL] [Abstract][Full Text] [Related]
7. A profile of volatile organic compounds in breath discriminates COPD patients from controls.
Van Berkel JJ; Dallinga JW; Möller GM; Godschalk RW; Moonen EJ; Wouters EF; Van Schooten FJ
Respir Med; 2010 Apr; 104(4):557-63. PubMed ID: 19906520
[TBL] [Abstract][Full Text] [Related]
8. Exhaled breath condensate levels of 8-isoprostane, growth related oncogene alpha and monocyte chemoattractant protein-1 in patients with chronic obstructive pulmonary disease.
Ko FW; Lau CY; Leung TF; Wong GW; Lam CW; Hui DS
Respir Med; 2006 Apr; 100(4):630-8. PubMed ID: 16213701
[TBL] [Abstract][Full Text] [Related]
9. Exhaled breath profiling in patients with COPD and OSA overlap syndrome: a pilot study.
Dragonieri S; Quaranta VN; Carratu P; Ranieri T; Resta O
J Breath Res; 2016 Nov; 10(4):041001. PubMed ID: 27811380
[TBL] [Abstract][Full Text] [Related]
10. Electronic nose breathprints are independent of acute changes in airway caliber in asthma.
Lazar Z; Fens N; van der Maten J; van der Schee MP; Wagener AH; de Nijs SB; Dijkers E; Sterk PJ
Sensors (Basel); 2010; 10(10):9127-38. PubMed ID: 22163399
[TBL] [Abstract][Full Text] [Related]
11. Discrimination between COPD patients with and without alpha 1-antitrypsin deficiency using an electronic nose.
Hattesohl AD; Jörres RA; Dressel H; Schmid S; Vogelmeier C; Greulich T; Noeske S; Bals R; Koczulla AR
Respirology; 2011 Nov; 16(8):1258-64. PubMed ID: 21883674
[TBL] [Abstract][Full Text] [Related]
12. Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD.
Fens N; de Nijs SB; Peters S; Dekker T; Knobel HH; Vink TJ; Willard NP; Zwinderman AH; Krouwels FH; Janssen HG; Lutter R; Sterk PJ
Eur Respir J; 2011 Dec; 38(6):1301-9. PubMed ID: 21700610
[TBL] [Abstract][Full Text] [Related]
13. Misdiagnosis of COPD and asthma in primary care patients 40 years of age and over.
Tinkelman DG; Price DB; Nordyke RJ; Halbert RJ
J Asthma; 2006; 43(1):75-80. PubMed ID: 16448970
[TBL] [Abstract][Full Text] [Related]
14. Is exhaled nitric oxide a useful adjunctive test for assessing asthma?
Bernstein JA; Davis B; Alvarez-Puebla MJ; Nguyen D; Levin L; Olaguibel JM
J Asthma; 2009 Nov; 46(9):955-60. PubMed ID: 19905926
[TBL] [Abstract][Full Text] [Related]
15. An electronic nose distinguishes exhaled breath of patients with Malignant Pleural Mesothelioma from controls.
Dragonieri S; van der Schee MP; Massaro T; Schiavulli N; Brinkman P; Pinca A; Carratú P; Spanevello A; Resta O; Musti M; Sterk PJ
Lung Cancer; 2012 Mar; 75(3):326-31. PubMed ID: 21924516
[TBL] [Abstract][Full Text] [Related]
16. Identification of airway bacterial colonization by an electronic nose in Chronic Obstructive Pulmonary Disease.
Sibila O; Garcia-Bellmunt L; Giner J; Merino JL; Suarez-Cuartin G; Torrego A; Solanes I; Castillo D; Valera JL; Cosio BG; Plaza V; Agusti A
Respir Med; 2014 Nov; 108(11):1608-14. PubMed ID: 25269711
[TBL] [Abstract][Full Text] [Related]
17. Assessment of exhaled breath condensate pH in exacerbations of asthma and chronic obstructive pulmonary disease: A longitudinal study.
Antus B; Barta I; Kullmann T; Lazar Z; Valyon M; Horvath I; Csiszer E
Am J Respir Crit Care Med; 2010 Dec; 182(12):1492-7. PubMed ID: 20656939
[TBL] [Abstract][Full Text] [Related]
18. The Influence of Smoking Status on Exhaled Breath Profiles in Asthma and COPD Patients.
Principe S; van Bragt JJMH; Longo C; de Vries R; Sterk PJ; Scichilone N; Vijverberg SJH; Maitland-van der Zee AH
Molecules; 2021 Mar; 26(5):. PubMed ID: 33806279
[TBL] [Abstract][Full Text] [Related]
19. Ambient temperature impacts on pH of exhaled breath condensate.
Koczulla AR; Noeske S; Herr C; Dette F; Pinkenburg O; Schmid S; Jörres RA; Vogelmeier C; Bals R
Respirology; 2010 Jan; 15(1):155-9. PubMed ID: 19947991
[TBL] [Abstract][Full Text] [Related]
20. Machine learning methods on exhaled volatile organic compounds for distinguishing COPD patients from healthy controls.
Phillips CO; Syed Y; Parthaláin NM; Zwiggelaar R; Claypole TC; Lewis KE
J Breath Res; 2012 Sep; 6(3):036003. PubMed ID: 22759349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
